PSA2016: The 25th Biennial Meeting of the Philosophy of Science Association

Full Program »

Inductive Risk and the Role of Values in Clinical Trials

This talk focuses on three debates regarding clinical trials: (1) whether evidence-based medicine is right to consider randomization the most important aspect of study design; (2) whether clinical trials should be pragmatic or explanatory in design; and (3) when clinical trials should use placebo controls. I will show that these debates can be understood in terms of differing positions on how to handle inductive risk. Moreover, this framing of the debates shows that methodological and ethical considerations are inextricably linked, which has important consequences for philosophical discussions of inductive risk and of the appropriate role for nonepistemic values in science.

Author Information:

Robyn Bluhm    
Michigan State University

 

Powered by OpenConf®
Copyright©2002-2015 Zakon Group LLC